1. bookVolume 15 (2022): Issue 1 (June 2022)
Journal Details
License
Format
Journal
eISSN
1313-9053
First Published
08 Sep 2014
Publication timeframe
2 times per year
Languages
English
Open Access

Demodicosis Cutis and Metabolic Disturbances

Published Online: 13 Jul 2022
Volume & Issue: Volume 15 (2022) - Issue 1 (June 2022)
Page range: 47 - 57
Received: 27 Aug 2021
Accepted: 11 May 2022
Journal Details
License
Format
Journal
eISSN
1313-9053
First Published
08 Sep 2014
Publication timeframe
2 times per year
Languages
English

1. Chen W, Plewig G. Human demodicosis: Revisit and a proposed classification. Br J Dermatol. 2014;170(6):1219-25.10.1111/bjd.12850 Search in Google Scholar

2. Powell F. Rosacea. In: Griffiths G, Barker J, Bleiker T, et. al., editors. Rook’s Textbook of Dermatology. Ninth. Chichester: John Wiley&Sons Ltd; 2016: 91.1-91.19. Search in Google Scholar

3. Asai Y, Tan J, Baibergenova A, Barankin B, Cochrane CL, Humphrey S, et al. Canadian clinical practice guidelines for rosacea. J Cutan Med Surg 2016 Sep 1;20(5):432-45.10.1177/1203475416650427 Search in Google Scholar

4. Tan J, Berg M. Rosacea: Current state of epidemiology. J Am Acad Dermatol [Internet]. 2013;69(6 SUPPL.1):27-35.10.1016/j.jaad.2013.04.043 Search in Google Scholar

5. Chosidow O, Cribier B. Epidemiology of rosacea: Updated data. In: Ann Dermatol Venereol. Elsevier Masson; 2011:179-83.10.1016/S0151-9638(11)70087-4 Search in Google Scholar

6. Two AM, Wu W, Gallo RL, Hata TR. Rosacea: Part I. Introduction, categorization, histology, pathogenesis, and risk factors. J Am Acad Dermatol. 2015 May 1;72(5):749-58.10.1016/j.jaad.2014.08.02825890455 Search in Google Scholar

7. Ozbagcivan O, Ozturk T, Akarsu S, Ilknur T, Fetil E. Evaluation of metabolic syndrome and its components in patients with rosacea: A cross-sectional, case-control study. Hong Kong J Dermatol. 2020;28(2):55-62. Search in Google Scholar

8. Searle T, Al-Niaimi F, Ali FR. Rosacea and the cardiovascular system. Vol. 19, J Cosmet Dermatol. Blackwell Publishing Ltd; 2020:2182-7.10.1111/jocd.1358732621366 Search in Google Scholar

9. Abram K, Silm H, Maaroos HI, Oona M. Risk factors associated with rosacea. J Eur Acad Dermatol Venereol. 2010;24(5):565-71.10.1111/j.1468-3083.2009.03472.x19874433 Search in Google Scholar

10. Chen Q, Shi X, Tang Y, Wang B, Xie H fu, Shi W, et al. Association between rosacea and cardiometabolic disease: A systematic review and meta-analysis. J Am Acad Dermatol. 2020 Nov 1;83(5):1331-40.10.1016/j.jaad.2020.04.11332360724 Search in Google Scholar

11. Forton FMN. Papulopustular rosacea, skin immunity and Demodex: Pityriasis folliculorum as a missing link. J Eur Acad Dermatol Venereol. 2012;26(1):19-28.10.1111/j.1468-3083.2011.04310.x22017468 Search in Google Scholar

12. Forton FMN. The Pathogenic Role of Demodex Mites in Rosacea: A Potential Therapeutic Target Already in Erythematotelangiectatic Rosacea? Vol. 10, Dermatology and Therapy. Adis; 2020:1229-53.10.1007/s13555-020-00458-9764919033095403 Search in Google Scholar

13. Forton FMN. Elucidating the role of Demodex folliculorum in the pathogenesis of rosacea: exciting first steps…. Br J Dermatol. 2018;179(2):252-3. Search in Google Scholar

14. Forton F, de Maertelaer V. Erythematotelangiectatic rosacea and subclinical demodicosis. Br J Dermatol. 2019;181(4):101-101.10.1111/bjd.18397 Search in Google Scholar

15. Forton FMN, de Maertelaer V. Rosacea and demodicosis: Little-known diagnostic signs and symptoms. Acta Derm Venereol. 2018;99(1):47-52. Search in Google Scholar

16. Forton FMN, de Maertelaer V. Two consecutive standardized skin surface biopsies: An improved sampling method to evaluate demodex density as a diagnostic tool for rosacea and demodicosis. Acta Derm Venereol. 2017;97(2):242-8.10.2340/00015555-252827573185 Search in Google Scholar

17. Forton FMN, de Maertelaer V. Treatment of rosacea and demodicosis with benzyl benzoate: effects of different doses on Demodex density and clinical symptoms. J Eur Acad Dermatol Venereol. 2019; 34(2):365-9. Search in Google Scholar

18. Forton FMN, de Maertelaer V. Papulopustular rosacea and rosacea-like demodicosis: two phenotypes of the same disease? J Eur Acad Dermatol Venereol. 2018 Jun 1;32(6):1011-6.10.1111/jdv.14885600180829478301 Search in Google Scholar

19. Forton F, Germaux MA, Brasseur T, de Liever A, Laporte M, Mathys C, et al. Demodicosis and rosacea: Epidemiology and significance in daily dermatologic practice. J J Am Acad Dermatol. 2005;52(1):74-87.10.1016/j.jaad.2004.05.03415627084 Search in Google Scholar

20. Tas Cengiz Z, Ozkol HU, Beyhan YE, Ozturk M, Yilmaz H. Evaluation of some chronical diseases in etiopathogenesis of demodicosis. Dermatologica Sin. 2017;35(4):173-6.10.1016/j.dsi.2017.04.006 Search in Google Scholar

21. Belli AA, Gok SO, Akbaba G, Etgu F, Dogan G. The relationship between rosacea and insulin resistance and metabolic syndrome. Eur J Dermatol. 2016;26(3):260-4.10.1684/ejd.2016.274827328660 Search in Google Scholar

22. Petersmann A, Müller-Wieland D, Müller UA, Landgraf R, Nauck M, Freckmann G, et al. Definition, Classification and Diagnosis of Diabetes Mellitus. Exp. Clin. Endocrinol. Diabetes. 2019;127(Suppl 1):1-7.10.1055/a-1018-907831860923 Search in Google Scholar

23. Tucker LA. Limited Agreement between Classifications of Diabetes and Prediabetes Resulting from the OGTT, Hemoglobin A1c, and Fasting Glucose Tests in 7412 U.S. Adults. J Clin Med. 2020;9(7):1-18.10.3390/jcm9072207740866732668564 Search in Google Scholar

24. Sánchez-García A, Rodríguez-Gutiérrez R, Mancillas-Adame L, González-Nava V, Díaz González-Colmenero A, Solis RC, et al. Diagnostic Accuracy of the Triglyceride and Glucose Index for Insulin Resistance: A Systematic Review. Int J Endocrinol. 2020;2020:1-7.10.1155/2020/4678526708584532256572 Search in Google Scholar

25. Altemani A, Alamri A, Ahmed M, al Garbo M, Alharbi T, Al-Rasheed R, et al. Prediabetes and serum insulin levels. Int JComm Med Pub H. 2018;5(5):1684-9.10.18203/2394-6040.ijcmph20181494 Search in Google Scholar

26. Hay RJ. Demodex and skin disease - False creation or palpable form? Vol. 170, Br J Dermatol. Blackwell Publishing Ltd; 2014. p. 1214-5.10.1111/bjd.1301524947148 Search in Google Scholar

27. Lacey N, Ní Raghallaigh S, Powell FC. Demodex mites - Commensals, parasites or mutualistic organisms?, Dermatol. 2011;22(2): 128-30.10.1159/00032300921228556 Search in Google Scholar

28. Lacey N, Russell-Hallinan A, Powell FC. Study of Demodex mites: Challenges and Solutions. J Eur Acad Dermatol Venereol. 2016;30(5):764-75.10.1111/jdv.1351726695086 Search in Google Scholar

29. Friedman P, Cohen Sabban E, Cabo H. Usefulness of dermoscopy in the diagnosis and monitoring treatment of demodicidosis. Dermatol Pract Concept. 2017;7(1):35-8.10.5826/dpc.0701a06531503828243492 Search in Google Scholar

30. Hsu CK, Hsu MML, Lee JYY. Demodicosis: A clinicopathological study. J Am Acad Dermatol [Internet]. 2009;60(3):453-62.10.1016/j.jaad.2008.10.05819231642 Search in Google Scholar

31. García-Vargas A, Mayorga-Rodríguez JA, Sandoval-Tress C. Scalp demodicidosis mimicking favus in a 6-year-old boy. J Am Acad Dermatol. 2007;57(2):19-21.10.1016/j.jaad.2006.04.08217637363 Search in Google Scholar

32. Fernandez-Flores A, Alija A. Scalp folliculitis with Demodex: Innocent observer or pathogen? Vol. 13, Braz J Infect Dis. 2009. p. 81-2.10.1590/S1413-8670200900020000120140347 Search in Google Scholar

33. Sanfilippo AM, English JC. Resistant scalp folliculitis secondary to Demodex infestation. Cutis.2005;76:321-4. Search in Google Scholar

34. Chuprov AD, Malgina EK. Modern aspects of etiopathogenetic treatment of ophthalmodemodicosis (literature review). Oftalmologiya.2018;15:281-5.10.18008/1816-5095-2018-2S-281-285 Search in Google Scholar

35. Huang Y, He H, Sheha H, Tseng SCG. Ocular demodicosis as a risk factor of pterygium recurrence. Ophthalmol. 2013;120(7):1341-7.10.1016/j.ophtha.2013.01.00123664471 Search in Google Scholar

36. Gao YY, Xu DL, Huang LJ, Wang R, Tseng SCG. Treatment of ocular itching associated with ocular demodicosis by 5% tea tree oil ointment. Cornea. 2012;31(1):14-7.10.1097/ICO.0b013e31820ce56c21955627 Search in Google Scholar

37. Cheng AMS, Sheha H, Tseng SCG. Recent advances on ocular Demodex infestation. Curr Opin Ophthalmol. 2015;26(4):295-300.10.1097/ICU.000000000000016826058028 Search in Google Scholar

38. Ewald B, Mrowietz U. Bilateral demodicosis of the nipple-areola complex. J Dtsch Dermatol Ges. 2019;17(7):733-4.10.1111/ddg.1384431012997 Search in Google Scholar

39. Douglas A, Zaenglein AL. A case series of demodicosis in children. Pediatr Dermatol. 2019;36(5):651-4.10.1111/pde.1385231197860 Search in Google Scholar

40. Álvarez-Salafranca M, Vicente A, Prat Torres C, Combalia A, Monsonís M, Celis-Passini VP, et al. Demodicosis in two patients with a previous history of Langerhans cell histiocytosis. Pediatr Dermatol. 2017;34(6):299-301.10.1111/pde.1328628940244 Search in Google Scholar

41. Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. European Heart Journal. 2017;38(32):2459-71.10.1093/eurheartj/ehx144583722528444290 Search in Google Scholar

42. Rainer BM, Kang S, Chien AL. Rosacea: Epidemiology, pathogenesis, and treatment. Derm.-Endocrinol. 2017;9(1):1938-72. Search in Google Scholar

43. Li Y, Guo L, Hao D, Li X, Wang Y, Jiang X. Association between Rosacea and Cardiovascular Diseases and Related Risk Factors: A Systematic Review and Meta-Analysis. Biomed Res Int. 2020;2020:1-11.10.1155/2020/7015249732028532685519 Search in Google Scholar

44. Katsambas A, Dessinioti C. The changing faces of acne, rosacea, and hidradenitis suppurativa. Clin Dermatol. 2017;35 (2):114-7.10.1016/j.clindermatol.2016.10.00228274347 Search in Google Scholar

45. Ünal E, Güvendi Akçınar U, Arduç A. Hidradenitis Suppurativa, Metabolic Syndrome, and Demodex spp. Infestation. Turkiye Parazitol Derg. 2018; 42(2):171-4. Search in Google Scholar

46. Tang Q, Li X, Song P, Xu L. Optimal cut-off values for the homeostasis model assessment of insulin resistance (HOMA-IR) and pre-diabetes screening: Developments in research and prospects for the future. Drug Discov Ther. 2015;9(6):380-5.10.5582/ddt.2015.0120726781921 Search in Google Scholar

47. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International. Circulation. 2009;120(16):1640-5.10.1161/CIRCULATIONAHA.109.19264419805654 Search in Google Scholar

48. Brož J, Malinovská J, Nunes MA, Kučera K, Rožeková K, Žejglicová K, et al. Prevalence of diabetes and prediabetes and its risk factors in adults aged 25–64 in the Czech Republic: A cross-sectional study. Diabetes Res Clin Pract 2020; 170:108470.10.1016/j.diabres.2020.10847032998019 Search in Google Scholar

49. Chen YH, Lee YC, Tsao YC, Lu MC, Chuang HH, Yeh WC, et al. Association between high-fasting insulin levels and metabolic syndrome in non-diabetic middle-aged and elderly populations: A community-based study in Taiwan. BMJ Open. 2018;8(5):1-7.10.1136/bmjopen-2017-016554594246829724734 Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo